Ally Bridge Group’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Ally Bridge Group’s Portfolio LYRA Stock Details LYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,075	Closed	-$6.24M	–	27
2024 Q1	$6.24M	Buy	+20,075	New	+$5.35M	3.47%	16

Other funds holding LYRA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ally Bridge Group's LYRA Position: Q2 2024 in Review

Ally Bridge Group sold out of LYRA THERAPEUTICS INC (LYRA) in Q2 2024, closing a stake of 20,075 shares — an estimated $6.24M sold.

Ally Bridge Group first reported a position in LYRA in Q1 2024 and held it in 1 quarter. The position peaked at $6.24M in Q1 2024. 51 funds tracked by Wall St. Rank hold LYRA as of Q2 2024.

Ally Bridge Group reported no remaining LYRA THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
Ally Bridge Group sold 20,075 LYRA THERAPEUTICS INC shares in Q2 2024, an estimated $6.24M.
Ally Bridge Group first reported a position in LYRA THERAPEUTICS INC in Q1 2024 and held it in 1 quarter.
Ally Bridge Group's LYRA THERAPEUTICS INC position peaked at $6.24M in Q1 2024.
51 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q2 2024.

Based on Ally Bridge Group's 13F filing for Q2 2024, filed 14 Aug 2024.